Banco Sabadell is launching the third edition of BStartup Health call for proposals to support three early stage start-ups in the healthcare sector with an investment of €100,000 and strategic mentoring. The deadline for applications is 20 May 2020.
The projects will be evaluated based on their potential for growth and scalable, innovative business models.
The scientific committee is made up of Clara Campàs, founding partner at Asabys; Carlos Gallardo, CEO of CG Health and Almirall board member; Damià Tormo, partner of Columbus Venture Partners and CEO of Artax Biofarma; and Montserrat Vendrell, partner at Alta Life Science. Genesis Biomed will analyse the proposals received.
The start-ups selected in previous calls are Able Human Motion, Admit Therapeutics, Creatsens, Oxolife, Miwendo and Doppli.
El equipo de investigadores observó cambios en el...
El gen AtCDF3 promueve una mayor producción de az...
Un estudio con datos de los últimos 35 años, ind...
En nuestro post hablamos sobre este interesante tipo de célula del si...
Este artículo explora el estado actual de la innovación farmacéutic...
